Connect with us

Entrepreneur

Career, family and the motherhood penalty that lies ahead

Published

on

As UK childcare costs account for 26 per cent of household income, fintech entrepreneur Mel Faxon explains why motherhood means that women can’t have it all. 

Mel joins me from her London coworking space. “Being able to walk over to someone’s desk, especially when you’re in a start-up, makes such a huge difference. I can’t wait until we have an office” she candidly admits.

Faxon met Siran Cao, her now co-founder, in 2019. As two millennial women, they started looking at why we often refuse to think about our bodies and careers on the same track. A few coffee conversations later, they decided to make a change in the way we perceive the idea of starting a family and they created Mirza, a care now pay later product that aims to distribute the costs of childcare over time and close the gender pay gap.

“When we first started, we were looking at the causes of the motherhood penalty and the decline in earnings that a woman sees after she has a child,” Faxon says. “This is one of the biggest contributors to the gender pay gap and if you don’t have good parental or maternity leave, it can hurt your career acceleration down the line.”

Taking time out of the workforce after stepping into motherhood is something that women naturally do, mainly because they can’t afford the increasing costs of childcare. However, the long-term financial implications are a lot bigger than we might think, the entrepreneur adds.

“We wanted to tackle this issue by launching a product that helps women keep working and that distributes the [childcare] costs over time to when they have higher earning potential,” she explains. “We want to allow women to take this zero-interest financing mechanism through their employer without having to choose between family and career.”

Mirza was initially aimed for women, but the two co-founders soon realised parenthood shouldn’t be one-sided.  “We wanted a family-focused financial planning product that helps parents understand what the parenthood penalty looks like and what taking unpaid leave looks like,” Faxon says.

“Once we realised that this is not just about women, we decided to shift [our idea] and make it much more gender neutral for both men and women.

“We constantly hear things like ‘I don’t want to have to choose between family and career’ or ‘women can have it all’. But right now, it’s unrealistic to think that women can have it all unless they have a lot of privilege and support.”

With one in three childcare centres shutting down in the US and over two million women dropping out of work during the pandemic, the need for a change seemed even more imperative.

“Covid has been a really good spotlight,” the co-founder adds. “This great resignation really highlights that people aren’t going to go back to work in places where they don’t get the support that they need and it also shows that care is the future of work. If we don’t support parents in their childcare needs, they are not going to be able to participate in the economy and help it grow.”

But why is financial planning so important in this process?

“Everything gets so disorganised when you have a child,” Faxon explains. “You don’t know where to go and you feel like you don’t have a balance between your career, what you were doing in the past and your current life.

“Financial planning helps people be a little bit more proactive. Having a child, then looking for childcare and realising what the expense is going to be, is very much a reactive approach that can mean that one of the parents would have to stay home.

“We want to help parents start these conversations ahead of time to help facilitate that dialogue around parental leave policies and statutory leaving,” she continues. “That would give them a sense of control and would help them navigate that with their employer.”

Mirza is purely tech-driven and is able to source some of the expenses that are coming up and taking your income into account, it will estimate the upcoming cost of care for the coming five to ten years. It is already available in the US, mainly because the data used was based on a US model.

“Both my co-founder and I are American. So, it felt a little bit more genuine for us to tackle those problems there,” Faxon says. “But our whole team is here, in London and we would love to expand it to the UK in a few years.”

Mirza’s five-year goal is to shape parental leave and have over two million families using the service. “Our vision is to become almost like a neobank of offering more tailored financial products for families ,” the co-founder adds.

“Women shouldn’t have to take that financial hit right when they have their first child and I hope we will change that.”

To find more about Mirza visit heymirza.com.

Entrepreneur

Kate Ryder headlines Women’s Health Week USA 2026 as full agenda goes live

Published

on

Women’s Health Week USA 2026 has unveiled its first populated agenda, anchored by an opening keynote from Kate Ryder, Founder and CEO of Maven Clinic, and featuring a cross-sector lineup shaping the next phase of scale in women’s health.

You can view the full agenda here.

Taking place May 13–14, 2026, at the New York Academy of Medicine, Women’s Health Week USA brings together the full women’s health ecosystem to focus on one central question: what does it take to move women’s health from innovation to institutional scale?

Kate Ryder will open Day 1 with a keynote drawing on her experience building Maven Clinic into the world’s largest virtual clinic for women’s and family health.

Under her leadership, Maven has partnered with employers and health plans to deliver care across fertility, maternity, postpartum, paediatrics, and menopause at scale.

Her perspective sets the tone for a program centered on commercialisation, partnership, and sustainable growth.

Beyond the opening keynote, the newly released agenda reflects the sector’s growing maturity.

Across two days, the program features 70+ speakers, with representation from leading organizations including the FDA, Planned Parenthood, CVS Health Ventures, Samsung Next, NIH, WHO, and Maven Clinic.

Sessions span investment and deal flow, clinical innovation, regulation, data and technology, and market expansion, alongside dedicated pitch sessions and curated 1:1 matchmaking designed to turn insight into action.

The agenda has been built to facilitate meaningful connections across the ecosystem, with partnerships positioned as the primary driver of scale.

As women’s health continues to attract institutional capital and global attention, Women’s Health Week USA 2026 offers a clear snapshot of where the market is heading, and who is shaping it.

The full agenda is now live, with additional speakers and partners to be announced in the coming months.

View the full programme here.

Continue Reading

Entrepreneur

Merck partners on intravaginal drug delivery device

Published

on

Calla Lily Clinical Care has partnered with Merck to support the intravaginal drug delivery platform Callavid in an effort to improve how vaginal medicines are given.

The collaboration will continue development of Callavid, described as a leak-resistant device that addresses challenges with self-administered vaginal therapies.

Callavid uses a small, tampon-shaped device with an integrated absorbent liner. It is inserted, remains in place during drug absorption, then is removed.

The platform is intended for use with medicines in fertility treatment, oncology and hormone therapy. Administration via the vaginal route can prompt patient anxiety about positioning, dosing accuracy and leakage.

The partnership is the first industry collaboration for the Callavid technology, which was developed by Calla Lily Clinical Care.

Thang Vo-Ta, co-founder and chief executive of Calla Lily Clinical Care, said: “This collaboration with Merck marks an important milestone in the development of Callavid, our novel vaginal drug delivery platform.

“Merck’s scientific heritage and forward-looking approach to innovation make them an ideal partner as we work to address long-standing unmet needs in women’s health.

“By improving how vaginal therapeutics are delivered and experienced, Callavid has the potential to enhance both patient outcomes and quality of life.

“We see this collaboration as a meaningful step towards translating our technology into real-world clinical and patient impact.”

Calla Lily Clinical Care is seeking to develop what it describes as the world’s first drug-device combination product to prevent threatened miscarriage and for IVF luteal phase support, the phase after ovulation when the body produces progesterone to support early pregnancy.

The device is also being developed to deliver therapeutics for oncology, menopause, infectious diseases and live biotherapeutics to reduce repeated antibiotic use.

Dr Lara Zibners, co-founder and chairman of Calla Lily Clinical Care, said: “Our initial engagement with Merck through the Merck Innovation Challenge in October 2024 was an important moment of alignment around the need for more patient-centric innovation in women’s health.

“As both a clinician and a patient, I have seen how profoundly drug delivery can shape treatment experience.

“This collaboration builds on that early dialogue and reflects a shared interest in rigorously exploring new approaches that may improve how therapies are delivered and experienced by patients.”

Continue Reading

Entrepreneur

US startup builds wearable hormone tracker

Published

on

Stanford graduates’ startup Clair is building a wearable hormone tracker for women, offering continuous, non-invasive monitoring.

The company, Clair, founded by Jenny Duan and Abhinav Agarwal, aims to build what its founders describe as a research-led, privacy-focused tool to help women see how hormone levels affect daily life.

Duan and Agarwal met in spring 2025 and began working on Clair shortly after. Over the past six months, they have been developing the technology and refining the company’s mission.

The device is designed to address gaps in women’s healthcare. Women remain underrepresented in medical research and clinical trials, leading to limited data and slower progress in understanding women’s health conditions.

According to Clair advisor and Stanford Medicine professor Brindha Bavan, hormone tracking in reproductive healthcare “improves our understanding of the function of and communication between the brain’s pituitary gland and ovaries or testes.

The pituitary gland is a small organ at the base of the brain that produces hormones regulating many bodily functions. The ovaries and testes are the primary reproductive organs that also produce sex hormones.

Hormonal health affects not only fertility and reproduction but also mental health, metabolism, energy levels and overall wellbeing.

Bavan said hormone tracking can “provide insight into menstrual cycle patterns and can aid with both diagnosing and assessing treatment for [various] conditions.”

“[Clair enables] patients [to] gain insight into their personal hormone fluctuations over different time periods,” Bavan said, “and share this information at healthcare visits to better understand and correlate any medical issues they are facing and avoid repeat blood draws.”

The device, which resembles a bracelet worn on the wrist, will connect to a mobile app, allowing all data processing to occur directly on the user’s phone rather than in external data centres.

“The device connects with an app so all of the processing happens on the app itself, not in a data centre like other devices. This is especially important given the current political climate around data privacy,” Agarwal said.

Clair also plans to pursue FDA approval and position itself as a medically credible device rather than solely a lifestyle product. The company is planning to launch a clinical trial at Stanford Medicine this spring.

Duan’s interest in women’s health and technology began as a Stanford undergraduate. At TreeHacks in 2024, she built apps focused on endometriosis, a condition where tissue similar to the lining of the womb grows outside of it.

She said a course on Philanthropy for Sustainable Development was particularly influential. “It was this class that sparked my interest in building a solution in [the women’s healthcare] space,” Duan said.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.